Lucia Bertuccini1, Manuela Costanzo2, Francesca Iosi1, Antonella Tinari1, Fabio Terruzzi3, Laura Stronati2, Marina Aloi4, Salvatore Cucchiara4, Fabiana Superti5. 1. Department of Technology and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy. 2. ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Department of Radiobiology and Human Health, Via Anguillarese 301, 00123 Rome, Italy. 3. Giellepi S.p.A., Via G. Verdi, 41/Q, 20831 Seregno (MB), Italy. 4. Department of Pediatrics, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy. 5. Department of Technology and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy. Electronic address: fabiana.superti@iss.it.
Abstract
BACKGROUND: Crohn's disease is a multifactorial disease in which an aberrant immune response to commensal intestinal microbiota leads to chronic inflammation. The small intestine of patients with Crohn's disease is colonized by a group of adherent-invasive Escherichia coli strongly able to adhere and invade intestinal epithelial cells lactoferrin is an iron-binding glycoprotein known to have anti-bacterial and anti-inflammatory activities. AIMS: We explore the ability of bovine lactoferrin to modulate the interactions between the adherent-invasive E. coli strain LF82 and intestinal epithelial cells as well as the inflammatory response. METHODS: Bacterial adhesion and invasion assays were used to assess the antimicrobial activity of lactoferrin. Electron microscopy was used to characterize bacteria-cell interactions. The mRNA expression of pro-inflammatory cytokines was measured both in cultured cells and in biopsies taken from intestine of patients affected by Crohn's disease. RESULTS: Lactoferrin inhibited bacterial invasion through minimally affecting adhesion. This divergence was due to a mannose-dependent lactoferrin binding to the bacterial type 1 pili and consequent bacterial aggregation on the intestinal epithelial cell surface. Expression of pro-inflammatory cytokines, such as TNF-alpha, IL-8, and IL-6, was markedly inhibited by lactoferrin both in cultured and Crohn-derived intestinal cells. CONCLUSIONS: Bovine lactoferrin might function via an antibacterial and/or anti-inflammatory mechanism in the treatment of Crohn's disease.
BACKGROUND:Crohn's disease is a multifactorial disease in which an aberrant immune response to commensal intestinal microbiota leads to chronic inflammation. The small intestine of patients with Crohn's disease is colonized by a group of adherent-invasive Escherichia coli strongly able to adhere and invade intestinal epithelial cells lactoferrin is an iron-binding glycoprotein known to have anti-bacterial and anti-inflammatory activities. AIMS: We explore the ability of bovinelactoferrin to modulate the interactions between the adherent-invasive E. coli strain LF82 and intestinal epithelial cells as well as the inflammatory response. METHODS: Bacterial adhesion and invasion assays were used to assess the antimicrobial activity of lactoferrin. Electron microscopy was used to characterize bacteria-cell interactions. The mRNA expression of pro-inflammatory cytokines was measured both in cultured cells and in biopsies taken from intestine of patients affected by Crohn's disease. RESULTS:Lactoferrin inhibited bacterial invasion through minimally affecting adhesion. This divergence was due to a mannose-dependent lactoferrin binding to the bacterial type 1 pili and consequent bacterial aggregation on the intestinal epithelial cell surface. Expression of pro-inflammatory cytokines, such as TNF-alpha, IL-8, and IL-6, was markedly inhibited by lactoferrin both in cultured and Crohn-derived intestinal cells. CONCLUSIONS:Bovinelactoferrin might function via an antibacterial and/or anti-inflammatory mechanism in the treatment of Crohn's disease.
Authors: Rana Al-Sadi; Moustafa Youssef; Manmeet Rawat; Shuhong Guo; Karol Dokladny; Mohammad Haque; Martin D Watterson; Thomas Y Ma Journal: Am J Physiol Gastrointest Liver Physiol Date: 2018-12-13 Impact factor: 4.052
Authors: Maria Elisa Drago-Serrano; Rafael Campos-Rodríguez; Julio César Carrero; Mireya de la Garza Journal: Int J Mol Sci Date: 2017-03-01 Impact factor: 5.923
Authors: Ning Liu; Gang Feng; Xiaoying Zhang; Qingjuan Hu; Shiqiang Sun; Jiaqi Sun; Yanan Sun; Ran Wang; Yan Zhang; Pengjie Wang; Yixuan Li Journal: Front Nutr Date: 2021-11-25